LETTER
Antiparasitic Quinolines by Microwave-Assisted Coupling–Isomerization Reaction (MACIR)
361
References and Notes
(1) New address: Lehrstuhl für Organische Chemie, Institut für
Organische Chemie und Makromolekulare Chemie der
Heinrich-Heine-Universität Düsseldorf, Universitätsstraße
1, 40225 Düsseldorf, Germany.
(2) Wiesner, J.; Ortmann, R.; Jomaa, H.; Schlitzer, M. Angew.
Chem. Int. Ed. 2003, 43, 5274.
(
3) Gilles, M. H. Management of Severe Malaria: A Practical
Handbook, 2nd ed.; World Health Organization: Geneva,
Figure 1 Molecular structure of 3c
2000.
(
4) (a) O’Neill, P. M.; Mukhtar, A.; Stocks, P. A.; Randle, L. E.;
Hindley, S.; Ward, S. A.; Storr, R. C.; Bickley, J. F.; O’Neil,
I. A.; Maggs, J. L.; Hughes, R. H.; Winstanley, P. A.; Bray,
P. G.; Park, B. K. J. Med. Chem. 2003, 46, 4933.
Without isolation of intermediates, both the CIR and the
cyclocondensation take place in one step. Mechanistical-
ly, the formation of the quinoline core presumably occurs
via a base-mediated trans–cis isomerization equilibrium
under the microwave irradiation, followed by a conclud-
ing intramolecular condensation step. Interestingly, natu-
rally occurring quinoline alkaloids, such as 2-phenyl
quinoline (3a) or chimanine B (3f) can be prepared very
easily, very quickly, and in good yields. Starting with the
(b) Ridley, R. G.; Hofheinz, W.; Matile, H.; Jaquet, C.;
Dorn, A.; Masciadri, R.; Jolidon, S.; Richter, W. F.; Guenzi,
A.; Girometta, M. A.; Urwyler, H.; Huber, W.; Thaithong,
S.; Peters, W. Antimicrob. Agents Chemother. 1996, 40,
1
846. (c) Stocks, P. A.; Raynes, K. J.; Bray, P. G.; Park, B.
K.; O’Neill, P. M.; Ward, S. A. J. Med. Chem. 2002, 45,
975. (d) Vlahov, R.; Pavrushev, S.; Vlahov, J. Pure Appl.
4
1
,5-diamino 2,4-diiodobenzene (1f), in the sense of a
Chem. 1990, 62, 1303. (e) Madrid, P. B.; Sherrill, J.; Liou,
A. P.; Weisman, J. L.; DeRisi, J. L.; Kipling Guy, R. Bioorg.
Med. Chem. Lett. 2005, 15, 1015.
pseudo three-component reaction, the expected pyri-
doquinoline derivative 3i is accessible.
(
5) (a) Fournet, A.; Vagneur, B.; Richomme, P.; Bruneton, J.
Many quinolines have already been shown to possess an-
Can. J. Chem. 1989, 67, 2116. (b) Fournet, A.;
6
tileishmanial activity in vitro tests (IC = 12-100 mM).
5
0
Hocquemiller, R.; Roblot, F.; Cavé, A.; Richomme, P.;
Bruneton, J. J. Nat. Prod. 1993, 56, 1547. (c) Fournet, A.;
Barrios, A. A.; Muñoz, V.; Hocquemiller, R.; Cavé, A.;
Richomme, P.; Bruneton, J. Antimicrob. Agents Chemother.
Therefore, we have tested the 2-substituted quinoline de-
rivatives 3 at two concentrations with respect to their an-
tiparasitic
activity,
i.e.
against
trypanosomes
1993, 37, 859.
(
trypanosoma brucei rhodesiense, trypanosoma cruzi,
(
(
6) Fakhfakh, M. A.; Fournet, A.; Prina, E.; Mouscadet, J.-F.;
Franck, X.; Hocquemiller, R.; Figadere, B. Bioorg. Med.
Chem. 2003, 11, 5013.
leishmania donovani), and protozoans (plasmodium falci-
parum), all of them are responsible for the plagues of trop-
ical diseases such as sleeping sickness, leishmaniasis, or
malaria. Among the tested quinolines some representa-
tives display antiplasmodial activity at higher micromolar
levels. Therefore, the IC values against plasmodium fal-
7) (a) Steel, P. J. Coord. Chem. Rev. 1990, 106, 227. (b)Ernst,
S.; Kaim, W. J. Am. Chem. Soc. 1986, 108, 3578.
(c) Mamo, A.; Nicolleti, S.; Cam Tat, N. Molecules 2002, 7,
618. (d) Qaseer, H. Croat. Chim. Acta 2005, 78, 79.
5
0
(
8) Balasubramanian, M.; Keay, J. G. In Comprehensive
Hetrocyclic Chemistry II, Vol. 5; Katrizky, A. R.; Rees, C.
W.; Scriven, E. F. V., Eds.; Pergamon Press: Oxford, 1996,
Chap. 5.06, 245.
ciparum were determined for all quinoline derivatives 3.
The naphthyridine 3g showed also moderate activity
against plasmodium falciparum at lower micromolar con-
centration (IC 1.64 mg/mL).
5
0
(9) Manske, R. H. F.; Kukla, M. Org. React. 1953, 7, 59.
10) For a review on recent progress in the synthesis of
quinolines, see: Kouznetsov, V. V.; Mendez, L. Y.;
Mendelez Gomez, C. M. Curr. Org. Chem. 2005, 9, 141.
11) For recent quinoline syntheses, see e.g.: (a) Cho, C. K.; Oh,
B. H.; Shim, S. C. J. Heterocycl. Chem. 1999, 36, 1175.
(b) Cho, C. K.; Oh, B. H.; Shim, S. C. Tetrahedron Lett.
1999, 40, 1499. (c) Cho, C. K.; Oh, B. H.; Shim, S. C.; Oh,
D. H. J. Heterocycl. Chem. 2000, 37, 1315. (d) Cho, C. K.;
Oh, B. H.; Kim, J. S.; Kim, T.-J.; Shim, S. C. Chem.
Commun. 2000, 1885. (e) Sangu, K.; Fuchibe, K.; Akiyama,
T. Org. Lett. 2004, 6, 353. (f) Jacob, J.; Jones, W. D. J. Org.
Chem. 2003, 68, 3563. (g) Akiyama, T.; Nakashima, S.;
Yokota, K.; Fuchibe, K. Chem. Lett. 2004, 33, 922.
12) (a) Cho, C. S.; Lee, N. Y.; Kim, T.-J.; Shim, S. C.
J. Heterocycl. Chem. 2004, 41, 409. (b) Cho, C. S.
J. Organomet. Chem. 2005, 690, 4094.
(
In conclusion, we have developed a rapid and efficient
one-pot quinoline synthesis on the basis of MACIR of the
o-amino (hetero)aryl halides with propargyl alcohols
within 30 minutes and in good to excellent yields. First bi-
ological tests against selected parasites have revealed the
potential of new quinoline derivatives as antiparasitic
agents. Further studies directed to expand the synthetic
scope and the screening for compounds with higher activ-
ity are currently in progress.
(
Acknowledgment
(
Financial support of the Deutsche Forschungsgemeinschaft is gra-
tefully acknowledged. We also cordially thank Ms Annette Loos for
experimental assistance, Dr. Elisabeth Davioud-Charvet for valua-
ble discussions, and BASF AG for the generous donation of chemi-
cals.
(13) (a) Braun, R. U.; Ansorge, M.; Müller, T. J. J. Chem. Eur. J.
2006, 12, 9081. (b) Müller, T. J. J.; Ansorge, M.; Aktah, D.
Angew. Chem. Int. Ed. 2000, 39, 1253.
(
14) (a) Liao, W.-W.; Müller, T. J. J. Synlett 2006, 3469.
b) Schramm née Dediu, O. G.; Müller, T. J. J. Adv. Synth.
(
Catal. 2006, 348, 2565. (c) Schramm née Dediu, O. G.;
Müller, T. J. J. Synlett 2006, 1841.
Synlett 2008, No. 3, 359–362 © Thieme Stuttgart · New York